Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial
高危鼻咽癌患者接受标准放化疗联合同步及辅助卡瑞利珠单抗治疗：一项多中心、随机、开放标签的3期临床试验
期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2025-085863
You, Rui; Xu, Gui-Qiong; Ding, Xi; Liang, Jin-Hui; Liu, Zhi-Gang; Zou, Xiong; Liu, You-Ping; Hu, Guang-Yuan; Liu, Yi-Min; Duan, Chong-Yang; Liu, Li-Zhi; Zhang, Wei-Jing; Liu, Qian; Li, Hui-Feng; Ouyang, Yan-Feng; Duan, Xiao-Tong; Wang, Qin; Peng, Lan; Liang, Jiong-Lin; Feng, Zheng-Kai; Qin, Zi-Han; Liu, Xiao; He, Zhi-Kun; Zhang, Bin; Long, Guo-Xian; Jiang, Yan-Hui; Lei, Feng; Huang, Pei-Yu; Hua, Yi-Jun; Chen, Ming-Yuan
